Envestnet Asset Management Inc Incyte Corp Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 66,023 shares of INCY stock, worth $5.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,023
Previous 61,641 7.11%
Holding current value
$5.01 Million
Previous $3.74 Million 16.81%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$57.33 - $68.61 $251,220 - $300,649
4,382 Added 7.11%
66,023 $4.36 Million
Q2 2024

Aug 08, 2024
SELL
$51.18 - $63.75 $329,036 - $409,848
-6,429 Reduced 9.44%
61,641 $3.74 Million
Q1 2024

May 13, 2024
BUY
$56.55 - $66.59 $1.57 Million - $1.85 Million
27,743 Added 68.8%
68,070 $3.88 Million
Q4 2023

Feb 13, 2024
BUY
$52.16 - $64.19 $40,997 - $50,453
786 Added 1.99%
40,327 $2.53 Million
Q3 2023

Nov 13, 2023
BUY
$57.77 - $65.93 $1.21 Million - $1.38 Million
20,974 Added 112.96%
39,541 $2.28 Million
Q2 2023

Aug 04, 2023
SELL
$60.95 - $75.51 $122,082 - $151,246
-2,003 Reduced 9.74%
18,567 $1.16 Million
Q1 2023

May 11, 2023
BUY
$70.23 - $86.01 $1,825 - $2,236
26 Added 0.13%
20,570 $1.49 Million
Q4 2022

Feb 07, 2023
BUY
$67.18 - $84.11 $172,182 - $215,573
2,563 Added 14.25%
20,544 $1.65 Million
Q3 2022

Nov 10, 2022
BUY
$66.18 - $82.86 $329,841 - $412,974
4,984 Added 38.35%
17,981 $1.2 Million
Q2 2022

Aug 03, 2022
BUY
$66.18 - $83.18 $160,089 - $201,212
2,419 Added 22.87%
12,997 $987,000
Q1 2022

May 04, 2022
BUY
$66.02 - $79.71 $219,054 - $264,477
3,318 Added 45.7%
10,578 $840,000
Q4 2021

Feb 04, 2022
SELL
$63.34 - $74.11 $69,547 - $81,372
-1,098 Reduced 13.14%
7,260 $533,000
Q3 2021

Oct 07, 2021
SELL
$68.67 - $84.02 $191,039 - $233,743
-2,782 Reduced 24.97%
8,358 $575,000
Q2 2021

Aug 04, 2021
SELL
$79.87 - $87.53 $519,155 - $568,945
-6,500 Reduced 36.85%
11,140 $937,000
Q1 2021

May 04, 2021
SELL
$76.02 - $100.5 $396,520 - $524,208
-5,216 Reduced 22.82%
17,640 $1.43 Million
Q4 2020

Feb 02, 2021
BUY
$80.74 - $97.7 $292,117 - $353,478
3,618 Added 18.81%
22,856 $1.99 Million
Q3 2020

Oct 09, 2020
BUY
$85.07 - $109.69 $233,942 - $301,647
2,750 Added 16.68%
19,238 $1.73 Million
Q2 2020

Jul 08, 2020
SELL
$74.18 - $108.93 $87,458 - $128,428
-1,179 Reduced 6.67%
16,488 $1.71 Million
Q1 2020

Apr 23, 2020
BUY
$63.18 - $85.97 $153,464 - $208,821
2,429 Added 15.94%
17,667 $1.29 Million
Q4 2019

Feb 11, 2020
BUY
$73.04 - $95.72 $144,765 - $189,717
1,982 Added 14.95%
15,238 $1.33 Million
Q3 2019

Oct 17, 2019
BUY
$72.82 - $86.52 $304,169 - $361,394
4,177 Added 46.01%
13,256 $984,000
Q2 2019

Aug 02, 2019
SELL
$73.52 - $88.7 $150,642 - $181,746
-2,049 Reduced 18.41%
9,079 $771,000
Q1 2019

May 10, 2019
BUY
$63.56 - $88.17 $215,722 - $299,248
3,394 Added 43.88%
11,128 $957,000
Q4 2018

Feb 13, 2019
BUY
$58.5 - $69.94 $452,439 - $540,915
7,734 New
7,734 $492,000
Q3 2018

Nov 14, 2018
SELL
$61.75 - $74.23 $215,507 - $259,062
-3,490 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$60.85 - $83.98 $56,894 - $78,521
-935 Reduced 21.13%
3,490 $233,000
Q1 2018

May 09, 2018
SELL
$83.06 - $100.98 $82,478 - $100,273
-993 Reduced 18.33%
4,425 $353,000
Q4 2017

Feb 20, 2018
SELL
$93.56 - $116.6 $40,417 - $50,371
-432 Reduced 7.38%
5,418 $514,000
Q3 2017

Nov 13, 2017
SELL
$109.15 - $138.27 $117,772 - $149,193
-1,079 Reduced 15.57%
5,850 $682,000
Q2 2017

Aug 14, 2017
BUY
N/A
6,929
6,929 $873,000

Others Institutions Holding INCY

# of Institutions
641
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email